Nautilus Biotechnology, Inc.
US ˙ NasdaqGS ˙ US63909J1088

SecurityNAUT / Nautilus Biotechnology, Inc.
InsiderMurphy Matthew B.
This page shows the track record and history of Murphy Matthew B. insider trades in Nautilus Biotechnology, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Murphy Matthew B. in NAUT / Nautilus Biotechnology, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2025-09-04 20,000 0.6429 20,000 0.6429 12,858 1 0.6610 362 2.82
2022-08-15 7,500 2.8410 7,500 2.8410 21,308
2022-08-12 2,500 2.8500 2,500 2.8500 7,125
2021-08-13 5,000 7.5613 5,000 7.5613 37,806

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

NAUT / Nautilus Biotechnology, Inc. Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Murphy Matthew B. in NAUT / Nautilus Biotechnology, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

NAUT / Nautilus Biotechnology, Inc. Insider Trades
Insider Transaction History
File
Date
Trade
Date
Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price
Unit
Price
Units
Changed
Value
Changed (1K)
Remaining
Options
Remaining
Shares
2025-09-05 2025-09-04 4 Murphy Matthew B. NAUT Common Stock P - Purchase I 0.6429 20,000 13 74,140
2022-08-16 2022-08-15 4 Murphy Matthew B. NAUT Common Stock P - Purchase I 2.8410 7,500 21 54,140
2022-08-16 2022-08-12 4 Murphy Matthew B. NAUT Common Stock P - Purchase I 2.8500 2,500 7 46,640
2022-05-13 2022-05-12 4 Murphy Matthew B. NAUT Common Stock A - Award I 3.2800 10,000 33 44,140
2022-02-25 2022-02-25 4 Murphy Matthew B. NAUT Stock Option (Right to Buy) A - Award D 3.78 140,000 140,000
2021-08-13 2021-08-13 4 Murphy Matthew B. NAUT Common Stock P - Purchase I 7.5613 5,000 38 34,140
2021-08-04 2021-06-14 4 Murphy Matthew B. NAUT Stock Option (Right to Buy) A - Award D 10.10 326,526 326,526
2021-06-09 3 Murphy Matthew B. NAUT Common Stock I 29,140
P
Pasaran terbuka atau pembelian persendirian sekuriti bukan derivatif atau derivatif
S
Pasaran terbuka atau jualan persendirian sekuriti bukan derivatif atau derivatif
A
Pemberian, penganugerahan atau pemerolehan lain sekuriti daripada syarikat (seperti opsyen)
C
Penukaran derivatif
D
Penjualan atau pemindahan sekuriti kembali kepada syarikat
F
Pembayaran harga pelaksanaan atau liabiliti cukai menggunakan sebahagian daripada sekuriti yang diterima daripada syarikat
G
Hadiah sekuriti oleh atau kepada orang dalam
K
Swap ekuiti dan urus niaga lindung nilai yang serupa
M
Pelaksanaan atau penukaran sekuriti derivatif yang diterima daripada syarikat (seperti opsyen)
V
Transaksi dilaporkan secara sukarela pada Borang 4
J
Lain-lain (disertai dengan nota kaki yang menerangkan transaksi)